Molecular targeted therapies in breast cancer: where are we now?

Molecular targeted therapies in breast cancer: where are we now?

Item
http://www.wikidata.org/entity/Q36837565
Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.Messina: a novel analysis tool to identify biologically relevant molecules in disease.A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues.Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?Advances in novel drug delivery strategies for breast cancer therapy.First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites.Trial assessing individualized options for treatment for breast cancer: the TAILORx trial.
P2860

Molecular targeted therapies in breast cancer: where are we now?

Item
http://www.wikidata.org/entity/Q36837565
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Molecular targeted therapies in breast cancer: where are we now?
@en
type
label
Molecular targeted therapies in breast cancer: where are we now?
@en
prefLabel
Molecular targeted therapies in breast cancer: where are we now?
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Molecular targeted therapies in breast cancer: where are we now?
@en
P2093
P304
P31
P356
10.1016/J.BIOCEL.2007.04.015
P433
P478
P50
P577
P5875
P698